MLC‐2 (also myosin regulatory light chain [MRLC] [30]) phosphorylation is known to regulate muscle function, by enhancing the actin–myosin binding, as well as the calcium‐sensitivity and to be protective against heart dysfunction [30, 41, 42]. Here, MYL2 is linked to benign neoplasm.